The Safety of Available Immunotherapy for the Treatment of Glioblastoma

Explore this paper's citation graph

Summary

Based on the reviewed clinical trials, the current immunotherapies targeting GBM are safe and well-tolerated with minimal toxicities which should be noted.

Type
article
Published
2017-01-03
Cited by
26
References
93
Access
Open access

Keywords

Physics, Particle (ecology), Spin (aerodynamics), Phase (matter), Electron

References

Cited by

Related papers